{
  "@context": "aku-v2",
  "@type": "pharmacology",
  "@id": "vascular:pharmacology:antiplatelet:aspirin",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-07T00:54:00.000Z",
    "updated": "2026-01-07T00:54:00.000Z",
    "contributors": ["vascular-surgery-agent"],
    "confidence": 0.96,
    "status": "validated"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pharmacology",
    "type": "pharmacology",
    "difficulty": "foundational",
    "importance": "critical"
  },
  "content": {
    "identifier": "PHARM-010",
    "title": "Aspirin in Vascular Surgery",
    "definition": "Acetylsalicylic acid as cornerstone antiplatelet therapy for arterial disease prevention and treatment.",
    "concepts": [
      {
        "concept_id": "mechanism",
        "term": "Mechanism of Action",
        "definition": "Irreversible acetylation of cyclooxygenase-1 (COX-1) inhibiting thromboxane A2 synthesis.",
        "clinical_features": {
          "target": "COX-1 in platelets",
          "product_inhibited": "Thromboxane A2 (TXA2)",
          "effect": "Prevents platelet aggregation",
          "duration": "Lifespan of platelet (7-10 days)"
        }
      },
      {
        "concept_id": "dosing",
        "term": "Aspirin Dosing",
        "definition": "Recommended dosing for different vascular indications.",
        "clinical_features": {
          "primary_prevention": "Not routinely recommended (USPSTF 2022)",
          "secondary_prevention": "81-325 mg daily",
          "acute_acs": "162-325 mg loading dose",
          "post_intervention": ["81 mg daily long-term", "Higher doses for specific indications"]
        }
      },
      {
        "concept_id": "resistance",
        "term": "Aspirin Resistance",
        "definition": "Failure of aspirin to adequately inhibit platelet function.",
        "clinical_features": {
          "prevalence": "5-60% depending on definition",
          "mechanisms": ["Poor compliance", "Drug interactions (NSAIDs)", "Genetic polymorphisms", "Increased platelet turnover"],
          "testing": ["Light transmission aggregometry", "VerifyNow", "TEG platelet mapping"],
          "clinical_significance": "Controversial - routine testing not recommended"
        }
      },
      {
        "concept_id": "perioperative",
        "term": "Perioperative Aspirin Management",
        "definition": "Guidelines for aspirin use around surgical procedures.",
        "clinical_features": {
          "continue": ["Carotid surgery", "Coronary surgery", "Peripheral bypass", "Recent coronary stent"],
          "consider_holding": ["Intracranial surgery", "Spine surgery", "Very high bleeding risk"],
          "hold_duration": "7-10 days if discontinued"
        }
      }
    ],
    "clinical_features": {
      "side_effects": ["GI bleeding", "Hemorrhagic stroke", "Aspirin-exacerbated respiratory disease"],
      "gi_protection": "PPI co-prescription in high-risk patients"
    },
    "diagnostic_criteria": {
      "effectiveness": "Platelet function testing if resistance suspected"
    }
  },
  "relationships": [
    {"type": "synergistic_with", "target": "vascular:pharmacology:p2y12-inhibitors"},
    {"type": "used_in", "target": "vascular:procedures:bypass"},
    {"type": "secondary_prevention", "target": "vascular:pathology:arterial:pad"}
  ],
  "provenance": {
    "sources": [
      {"reference": "Antithrombotic Trialists' Collaboration. Lancet. 2009;373:1849-1860", "type": "meta-analysis"},
      {"reference": "CAPRIE Steering Committee. Lancet. 1996;348:1329-1339", "type": "primary"}
    ],
    "extraction_method": "expert-review"
  }
}
